The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed Mark Dybul, a former executive director of the organisation, as its next chief executive, with his four-year tenure scheduled to begin in early 2027.

The organisation announced this in a statement on Wednesday.

Mr Dybul’s appointment came amid changing global health financing realities, rapid scientific and technological advances, and evolving priorities in efforts to end AIDS, tuberculosis and malaria.

A medical doctor with more than 25 years of experience in HIV and public health, Mr Dybul previously served as executive director of the Global Fund from 2013 to 2017.

Earlier in his career, he played a significant role in developing the United States President’s Emergency Plan for AIDS Relief (PEPFAR), a long-standing Global Fund partner. He subsequently served as the U.S. Global AIDS coordinator from 2006 to 2009, helping to lead the initiative’s efforts to address the HIV/AIDS epidemic.

The chair of the Global Fund Board, Roslyn Morauta, said Mr Dybul brought exceptional experience, commitment and a proven record of delivering results in global health.

Ms Morauta said his understanding of the organisation’s partnership model and his experience in developing innovative approaches to healthcare would be valuable as the Global Fund adapted to changing global health realities.

She said that Mr Dybul had spent his career exploring innovative ways to save and improve lives, particularly in vulnerable communities.

Ms Morauta thanked outgoing executive director Peter Sands for his leadership since 2018, describing his tenure as marked by significant progress and exceptional global health challenges. She said Mr Sands’ continued commitment during the transition would help ensure that the organisation remained focused on its life-saving mission.

She said these advances had contributed to efforts to save millions of lives and accelerate progress against the three diseases.

The vice-chair of the Global Fund Board, Bience Gawanas, said the incoming executive director recognised the importance of country ownership, self-reliance and sustainable health systems.

According to Ms Gawanas, the organisation under Mr Dybul’s leadership will support countries in accelerating the transition to more sustainable healthcare systems while ensuring vulnerable populations are not left behind.

Before his appointment, Mr Dybul served as a professor of medicine at Georgetown University Medical Centre. He co-founded the university’s Centre for Global Health Practice and Impact, where he is Chief Strategy Officer.

(NAN)